Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 218 participants.
Also called NCT01240759
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 218 participants
- Sponsor
- Registry
-
NCT01240759
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01240759. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- S-707106 Dose A
- Intervention (Drug)
- S-707106 Dose B
- Intervention (Drug)
- S-707106 Dose C
- Intervention (Drug)
- Placebo A tablet
- Intervention (Drug)
- Metformin
- Lead sponsor
- Shionogi
Record details
- Record id
cardio:ct-nct01240759- Content hash
be5de1151f1dd90956c1728fd37caa18a77dc91cc3e537cb54b733045c1a2e95